NCT06010875 A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05990920 Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy Status COMPLETED Phase PHASE1
NCT05988697 Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib Status NOT_YET_RECRUITING Phase N/A
NCT05910541 The Efficacy of Multisession Mindful Breathing in Symptom Reduction Among Patients With Advanced Cancers Status COMPLETED Phase NA
NCT05894421 TQB2223 Injection in Combination With Penpulimab in Patients With Advanced Cancers Status RECRUITING Phase PHASE1
NCT05891171 Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05885984 Acceptance and Commitment Therapy on Fatigue Interference in Patients With Advanced Lung Cancer and Caregiver Burden (ACT) Status UNKNOWN Phase NA
NCT05884788 Study of the Life Stories of Patients Making a Request for Euthanasia, in the Context of Advanced Cancer. Status COMPLETED Phase N/A
NCT05877430 Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT05864144 A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05859074 A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer Status RECRUITING Phase PHASE1
NCT05853575 Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05840510 Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19) Status TERMINATED Phase PHASE1
NCT05812677 A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Cervical and Endometrial Cancer Status RECRUITING Phase EARLY_PHASE1
NCT05802420 The Value of Molecular Residual Disease Monitoring Based on ctDNA in Advanced or Metastatic Pancreatic Cancer Status UNKNOWN Phase NA